ArticleChembiochem : a European journal of chemical biology2016

A Nanobody Activation Immunotherapeutic that Selectively Destroys HER2-Positive Breast Cancer Cells.

Melissa A Gray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.